Perfusion CT helps decision making for thrombolysis when there is no clear time of onset

被引:48
作者
Hellier, KD
Hampton, JL
Guadagno, JV
Higgins, NP
Antoun, NM
Day, DJ
Gillard, JH
Warburton, EA
Baron, JC
机构
[1] Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England
[2] Addenbrookes Hosp, Dept Stroke Med, Cambridge CB2 2QQ, England
[3] Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England
[4] Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England
关键词
D O I
10.1136/jnnp.2005.067363
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Current guidelines on thrombolysis post stroke with recombinant tissue plasminogen activator (rt-PA) exclude its use where time of onset is unknown, thus denying some patients potentially beneficial treatment. Contrast enhanced perfusion computed tomography (pCT) imaging can be used together with plain CT and information on clinical deficits to decide whether or not thrombolysis should be initiated even though the exact time of stroke onset is unknown. Based on the results of pCT and CT, rt-PA was administered to two patients with unknown time of stroke onset; one of the patients also underwent suction thrombectomy. Results in both cases were excellent.
引用
收藏
页码:417 / 419
页数:3
相关论文
共 13 条
[1]   The stroke patient who woke up - Clinical and radiological features, including diffusion and perfusion MRI [J].
Fink, JN ;
Kumar, S ;
Horkan, C ;
Linfante, I ;
Selim, MH ;
Caplan, LR ;
Schlaug, G .
STROKE, 2002, 33 (04) :988-993
[2]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[3]  
Gillard JH, 2000, NEUROL RES, V22, P457
[4]   Reproducibility of quantitative CT perfusion imaging [J].
Gillard, JH ;
Antoun, NM ;
Burnet, NG ;
Pickard, JD .
BRITISH JOURNAL OF RADIOLOGY, 2001, 74 (882) :552-555
[5]   MERCI 1 - A phase 1 study of mechanical embolus removal in cerebral ischemia [J].
Gobin, YP ;
Starkman, S ;
Duckwiler, GR ;
Grobelny, T ;
Kidwell, CS ;
Jahan, R ;
Pile-Spellman, J ;
Segal, A ;
Vinuela, F ;
Saver, JL .
STROKE, 2004, 35 (12) :2848-2853
[6]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[7]   Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct [J].
Hjort, N ;
Butcher, K ;
Davis, SM ;
Kidwell, CS ;
Koroshetz, WJ ;
Röther, J ;
Schellinger, PD ;
Warach, S ;
Ostergaard, L .
STROKE, 2005, 36 (02) :388-397
[8]   Use of tissue-type plasminogen activator for acute ischemic stroke - The Cleveland area experience [J].
Katzan, IL ;
Furlan, AJ ;
Lloyd, LE ;
Frank, JI ;
Harper, DL ;
Hinchey, JA ;
Hammel, JP ;
Qu, A ;
Sila, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09) :1151-1158
[9]   Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke - A population-based study [J].
Kleindorfer, D ;
Kissela, B ;
Schneider, A ;
Woo, D ;
Khoury, J ;
Miller, R ;
Alwell, K ;
Gebel, J ;
Szaflarski, J ;
Pancioli, A ;
Jauch, E ;
Moomaw, C ;
Shukla, R ;
Broderick, JP .
STROKE, 2004, 35 (02) :E27-E29
[10]   Imaging viable brain tissue with CT scan during acute stroke [J].
Meuli, RA .
CEREBROVASCULAR DISEASES, 2004, 17 :28-34